Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schrek

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Medical Hypotheses|July 1, 1991
Intractable chronic lymphocytic leukemia and interferonR Schrek
Cancer Research|October 1, 1979
Utility and efficiency of viable cell countsR Schrek
Archives of Pathology|October 29, 2010
In vitro studies on the physiology of cells; interactions of thymic cells and an oxidation-reduction indicator, 2,6-dichlorophenolindophenolR SCHREK
Medical Hypotheses|July 1, 1992
Sensitivity of latent cancer to chemotherapyR Schrek
Medical Hypotheses|November 1, 1990
An animal model for intractable chronic lymphocytic leukemiaR Schrek
The New England Journal of Medicine|July 17, 1975
Letter: Sensitivity to colchicine as a test for leukemic lymphocytesR Schrek
Medical Hypotheses|February 1, 1990
Differences between responsive and intractable chronic lymphocytic leukemiaR Schrek
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
In vitro effects of oxytetracycline on normal and malignant cellsR SCHREK
Journal of the National Cancer Institute|January 1, 1972
Ultrastructure of blood lymphocytes from chronic lymphocytic and lymphosarcoma cell leukemiaR Schrek
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|December 1, 1974
Letter: Production of Rieder lymphocytes by x-irradiationR Schrek
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Medical Hypotheses|July 1, 1991
Intractable chronic lymphocytic leukemia and interferonR Schrek
Cancer Research|October 1, 1979
Utility and efficiency of viable cell countsR Schrek
Archives of Pathology|October 29, 2010
In vitro studies on the physiology of cells; interactions of thymic cells and an oxidation-reduction indicator, 2,6-dichlorophenolindophenolR SCHREK
Medical Hypotheses|July 1, 1992
Sensitivity of latent cancer to chemotherapyR Schrek
Medical Hypotheses|November 1, 1990
An animal model for intractable chronic lymphocytic leukemiaR Schrek
The New England Journal of Medicine|July 17, 1975
Letter: Sensitivity to colchicine as a test for leukemic lymphocytesR Schrek
Medical Hypotheses|February 1, 1990
Differences between responsive and intractable chronic lymphocytic leukemiaR Schrek
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
In vitro effects of oxytetracycline on normal and malignant cellsR SCHREK
Journal of the National Cancer Institute|January 1, 1972
Ultrastructure of blood lymphocytes from chronic lymphocytic and lymphosarcoma cell leukemiaR Schrek
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|December 1, 1974
Letter: Production of Rieder lymphocytes by x-irradiationR Schrek
Pageof 6